Article: Pragmatic rules for comparability of biological medicinal products
2020
Abstract: Comparability is a key concept in the evaluation of both manufacturing changes and biosimilars. It constitutes a pragmatic and flexible approach which recognises that biologicals are inherently variable and that minor variations in quality attributes are ...
Abstract | Comparability is a key concept in the evaluation of both manufacturing changes and biosimilars. It constitutes a pragmatic and flexible approach which recognises that biologicals are inherently variable and that minor variations in quality attributes are often clinically irrelevant. In this discussion paper, we argue that comparability exercises rely on a number of pragmatic criteria. These criteria have been remarkably robust for 20 years of comparability exercises; however, the increased scrutiny of biosimilar applications provides an impetus for both codification and improvement of criteria for establishing comparability. Such a more rigorous, methodologically sound, approach towards comparability seems both feasible and beneficial. |
---|---|
Keywords | biomedical research ; drugs ; manufacturing ; research methods |
Language | English |
Dates of publication | 2020-01 |
Size | p. 97-100. |
Publishing place | Elsevier Ltd |
Document type | Article |
ZDB-ID | 1017370-5 |
ISSN | 1095-8320 ; 1045-1056 |
ISSN (online) | 1095-8320 |
ISSN | 1045-1056 |
DOI | 10.1016/j.biologicals.2019.11.002 |
Database | NAL-Catalogue (AGRICOLA) |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 879: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.